Literature DB >> 24117873

Atrial flutter or fibrillation is the most frequent and life-threatening arrhythmia in myotonic dystrophy.

Béatrice Brembilla-Perrot1, Jérôme Schwartz, Olivier Huttin, Zied Frikha, Jean Marc Sellal, Nicholas Sadoul, Hugues Blangy, Arnaud Olivier, Sarah Louis, Pierre Kaminsky.   

Abstract

BACKGROUND: Several arrhythmias were reported in myotonic dystrophy (MD).
OBJECTIVES: To evaluate the prevalence of atrial fibrillation (AF) and atrial flutter (AFL) in MD and the clinical consequences.
METHODS: One hundred sixty-one patients, mean age 41 ± 14 years, were referred for a type 1 MD. All patients were asymptomatic except four patients and followed during 5 ± 4 years. Electrocardiogram (ECG), echocardiography assessing left ventricular ejection fraction, and Holter monitoring were obtained and repeated.
RESULTS: Twenty-seven patients (17%) presented sustained (>1 hour) AF (n = 15) or AFL (n = 12); two of them presented syncope-related 1/1 AFL. In one of them, 16 years of age, cardiac defibrillator was implanted for a diagnosis of ventricular tachycardia, but the true diagnosis was established after inappropriate shocks. AFL ablation was performed in five patients, but four developed AF. The other seven patients with AFL developed AF. During the follow-up, 22 patients died (14%) from cardiac and respiratory failure; eight patients with AF/AFL died (30%) while only 14 without AF/AFL died (10%; P < 0.01). Univariate analysis indicated that age >40 years (death: 48 ± 14 vs 40 ± 8 in alive patients), abnormal ECG, and occurrence of AF/AFL were significant factors of death. At multivariate analysis, AF at ECG (odds ratio: 3.12) and age >40 (odds ratio: 3.14) were the sole independent variables predicting death.
CONCLUSIONS: AF and AFL were frequent in MD and increased mortality. AFL could present as 1/1 AFL with a poor tolerance and a risk of misdiagnosis despite frequent conduction disturbances. This arrhythmia could explain wide QRS tachycardia occurring in MD and interpreted as VT. ©2013, The Authors. Journal compilation ©2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  atrial fibrillation; atrial flutter; myotonic dystrophy; prognosis

Mesh:

Year:  2013        PMID: 24117873     DOI: 10.1111/pace.12260

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  14 in total

1.  Usefulness of the external loop recorder in a patient with Myotonic Dystrophy type 1 and recurrent episodes of palpitations: evaluation of the follow-up from diagnosis to 6 month-post-cardiac interventional treatment.

Authors:  Anna Rago; Andrea Antonio Papa; Dario Galante; Antonio Cassese; Paolo Golino
Journal:  Acta Myol       Date:  2018-05-01

2.  A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.

Authors:  Elisabetta Bucci; Marco Testa; Loretta Licchelli; Alessandra Frattari; Nadia Attalla El Halabieh; Erica Gabriele; Giulia Pignatelli; Tiziana De Santis; Laura Fionda; Fiammetta Vanoli; Stefania Morino; Matteo Garibaldi; Antonella Di Pasquale; Nicola Vanacore; Annalisa Botta; Giovanni Antonini
Journal:  J Neurol       Date:  2018-02-10       Impact factor: 4.849

3.  Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.

Authors:  Ramesh S Yadava; Qing Yu; Mahua Mandal; Frank Rigo; C Frank Bennett; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

4.  Bachmann bundle pacing reduces atrial electromechanical delay in type 1 myotonic dystrophy patients.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Giulia Arena; Luisa Politano; Gerardo Nigro
Journal:  J Interv Card Electrophysiol       Date:  2018-02-27       Impact factor: 1.900

Review 5.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

6.  Pentamidine rescues contractility and rhythmicity in a Drosophila model of myotonic dystrophy heart dysfunction.

Authors:  Mouli Chakraborty; Estela Selma-Soriano; Emile Magny; Juan Pablo Couso; Manuel Pérez-Alonso; Nicolas Charlet-Berguerand; Ruben Artero; Beatriz Llamusi
Journal:  Dis Model Mech       Date:  2015-10-29       Impact factor: 5.758

Review 7.  Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention.

Authors:  Ryan J Koene; Wayne O Adkisson; David G Benditt
Journal:  J Arrhythm       Date:  2017-09-01

8.  Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population.

Authors:  Vincenzo Russo; Andrea Antonio Papa; Anna Rago; Paola D'Ambrosio; Giovanni Cimmino; Alberto Palladino; Luisa Politano; Gerardo Nigro
Journal:  Acta Myol       Date:  2016-10

Review 9.  Management of cardiac involvement in muscular dystrophies: paediatric versus adult forms.

Authors:  Alberto Palladino; Paola D'Ambrosio; Andrea Antonio Papa; Roberta Petillo; Chiara Orsini; Marianna Scutifero; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2016-12

10.  Atrial fibrillation burden in Myotonic Dystrophy type 1 patients implanted with dual chamber pacemaker: the efficacy of the overdrive atrial algorithm at 2 year follow-up.

Authors:  Vincenzo Russo; Gerardo Nigro; Anna Rago; Andrea Antonio Papa; Riccardo Proietti; Nadia Della Cioppa; Anna Cristiano; Alberto Palladino; Raffaele Calabrò; Luisa Politano
Journal:  Acta Myol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.